Serum cytokine levels and other associated factors as possible immunotherapeutic targets and prognostic indicators for lung cancer
Frontiers in Oncology · 16.02.2023 · 13
DOI: 10.3389/fonc.2023.1064616 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 16.02.2023. Verfasst von Yinghao Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Second Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lung cancer is one of the most prevalent cancer types and the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) accounts for 80-85% of all cancer incidences. Lung cancer therapy and prognosis largely depend on the disease’s degree at the diagnosis time. Cytokines are soluble polypeptides that contribute to cell-to-cell communication, acting paracrine or autocrine on neighboring or distant cells. Cytokines are essential for developing neoplastic growth, but they are also known to operate as biological inducers following cancer therapy. Early indications are that inflammatory cytokines such as IL-6 and IL-8 play a predictive role in lung cancer. Nevertheless, the biological significance of cytokine levels in lung cancer has not yet been investigated. This review aimed to assess the existing literature on serum cytokine levels and additional factors as potential immunotherapeutic targets and lung cancer prognostic indicators. Changes in serum cytokine levels have been identified as immunological biomarkers for lung cancer and predict the effectiveness of targeted immunotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The Second Hospital of Jilin University, Changchun, China.
- Department of Hepatopancreatobiliary Medicine, The Second Hospital of Jilin University, Changchun, Jilin, China.
- Department of Central Lab, The Second Hospital of Jilin University, Changchun, China.
- Department of Pathology, The Second Hospital of Jilin University, Changchun, China.
Zitieren
APA
Zhao, Y., Jia, S., Zhang, K., & Zhang, L. (2023). Serum cytokine levels and other associated factors as possible immunotherapeutic targets and prognostic indicators for lung cancer. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1064616
Vancouver
Zhao Y, Jia S, Zhang K, Zhang L. Serum cytokine levels and other associated factors as possible immunotherapeutic targets and prognostic indicators for lung cancer. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1064616
BibTeX
@article{Zhao2023,
author = {Zhao, Yinghao and Jia, Shengnan and Zhang, Kun and Zhang, Lian},
title = {Serum cytokine levels and other associated factors as possible immunotherapeutic targets and prognostic indicators for lung cancer},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1064616}
}
EUVIMED